Assessment of stability, toxicity and immunogenicity of new polymeric nanoreactors for use in enzyme replacement therapy of MNGIE.

The lack of a crucial metabolic enzyme can lead to accumulating substrate concentrations in the bloodstream and severe human enzyme deficiency diseases. Mitochondrial Neurogastrointestinal Encephalomyopathy (MNGIE) is such a fatal genetic disorder, caused by a thymidine phosphorylase deficiency. Enzyme replacement therapy is a strategy where the deficient enzyme is administered intravenously in order to decrease the toxic substrate concentrations. Such a therapy is however not very efficient due to the fast elimination of the native enzyme from the circulation. In this study we evaluate the potential of using polymeric enzyme-loaded nanoparticles to improve the delivery of therapeutic enzymes. We constructed new 200-nanometer PMOXA-PDMS-PMOXA polymeric nanoparticles that encapsulate the enzyme thymidine phosphorylase. These particles are permeabilised for substrates and products by the reconstitution of the nucleoside-specific porin Tsx in their polymeric wall. We show that the obtained 'nanoreactors' are enzymatically active and stable in blood serum at 37 degrees C. Moreover, they do not provoke cytotoxicity when incubated with hepatocytes for 4 days, nor do they induce a macrophage-mediated inflammatory response ex vivo and in vivo. All data highlight the potential of such nanoreactors for their application in enzyme replacement therapy of MNGIE.

[1]  J. Rosenbusch,et al.  Coupling site-directed mutagenesis with high-level expression: large scale production of mutant porins from E. coli. , 1998, FEMS microbiology letters.

[2]  C. Korzeniewski,et al.  An enzyme-release assay for natural cytotoxicity. , 1983, Journal of immunological methods.

[3]  Mathias Winterhalter,et al.  Amphiphilic block copolymer nanocontainers as bioreactors , 2001 .

[4]  I. Nishino,et al.  Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. , 1999, Science.

[5]  Thomas Hirt,et al.  Polymerized ABA Triblock Copolymer Vesicles , 2000 .

[6]  T. Vanhaecke,et al.  Trichostatin A, a critical factor in maintaining the functional differentiation of primary cultured rat hepatocytes. , 2007, Toxicology and applied pharmacology.

[7]  D. Zukor,et al.  Cytotoxicity and macrophage cytokine release induced by ceramic and polyethylene particles in vitro. , 1999, The Journal of bone and joint surgery. British volume.

[8]  Stephan Marsch,et al.  Inhibition of Macrophage Phagocytotic Activity by a Receptor-targeted Polymer Vesicle-based Drug Delivery Formulation of Pravastatin , 2008, Journal of cardiovascular pharmacology.

[9]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[10]  R. Schiffmann,et al.  Clinical features of and recent advances in therapy for Fabry disease. , 2000, JAMA.

[11]  M. Nakakura,et al.  Release of drugs from liposomes varies with particle size. , 2007, Biological & pharmaceutical bulletin.

[12]  Stephan Marsch,et al.  Cell targeting by a generic receptor-targeted polymer nanocontainer platform. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Jan Steyaert,et al.  Therapeutic nanoreactors: combining chemistry and biology in a novel triblock copolymer drug delivery system. , 2005, Nano letters.

[14]  W. Meier,et al.  Hybrid materials from amphiphilic block copolymers and membrane proteins. , 2002, Journal of biotechnology.

[15]  T. Vanhaecke,et al.  Isolation of rat hepatocytes. , 1998, Methods in molecular biology.

[16]  V. Gaberc-Porekar,et al.  Obstacles and pitfalls in the PEGylation of therapeutic proteins. , 2008, Current opinion in drug discovery & development.

[17]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[18]  I. Nishino,et al.  Altered Thymidine Metabolism Due to Defects of Thymidine Phosphorylase* , 2002, The Journal of Biological Chemistry.

[19]  N. Kiyosawa,et al.  Molecular mechanism investigation of cycloheximide-induced hepatocyte apoptosis in rat livers by morphological and microarray analysis. , 2006, Toxicology.

[20]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[21]  Dennis E. Discher,et al.  Polymer Vesicles , 2022 .

[22]  R. Desnick,et al.  Long-term safety and efficacy of enzyme replacement therapy for Fabry disease. , 2004, American journal of human genetics.

[23]  Michael L Klein,et al.  Emerging Applications of Polymersomes in Delivery: from Molecular Dynamics to Shrinkage of Tumors. , 2007, Progress in polymer science.

[24]  T. Heath,et al.  Serum-induced leakage of negatively charged liposomes at nanomolar lipid concentrations. , 1990, Biochemistry.

[25]  Parag Aggarwal,et al.  Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. , 2008, Molecular pharmaceutics.

[26]  H. Krug,et al.  Oops they did it again! Carbon nanotubes hoax scientists in viability assays. , 2006, Nano letters.

[27]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[28]  J. M. Harris,et al.  Effect of pegylation on pharmaceuticals , 2003, Nature Reviews Drug Discovery.

[29]  W. Oyen,et al.  Factors affecting the accelerated blood clearance of polyethylene glycol-liposomes upon repeated injection. , 2001, The Journal of pharmacology and experimental therapeutics.

[30]  J. Charrow,et al.  Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trial , 2001, Genetics in Medicine.

[31]  S. Nagata,et al.  The Fas death factor , 1995, Science.

[32]  Y. Barenholz,et al.  Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin. , 1991, British Journal of Cancer.

[33]  B. Grosbois,et al.  Gaucher disease. , 2008, Joint, bone, spine : revue du rhumatisme.

[34]  Jos H Beijnen,et al.  An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. , 2003, Toxicology and applied pharmacology.

[35]  N. Chaniotakis,et al.  Pesticide detection with a liposome-based nano-biosensor. , 2007, Biosensors & bioelectronics.

[36]  Vesa-Pekka Lehto,et al.  Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles. , 2007, Chemical research in toxicology.

[37]  P. Chinnery,et al.  Treating MNGIE , 2006, Neurology.

[38]  J. Dambrosia,et al.  Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease. , 1991, The New England journal of medicine.

[39]  H. Harashima,et al.  Liposome Clearance , 2002, Bioscience reports.

[40]  V. Torchilin,et al.  Biodegradable long-circulating polymeric nanospheres. , 1994, Science.

[41]  B. van den Berg,et al.  Crystal structure of the bacterial nucleoside transporter Tsx , 2004, The EMBO journal.

[42]  V. Carelli,et al.  Thymidine and deoxyuridine accumulate in tissues of patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) , 2007, FEBS letters.

[43]  V. Singh,et al.  The role of nitric oxide in inflammatory reactions. , 2007, FEMS immunology and medical microbiology.

[44]  Y. Anikster,et al.  Infusion of platelets transiently reduces nucleoside overload in MNGIE , 2006, Neurology.

[45]  M. Hershfield,et al.  PEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 years. , 1995, Clinical immunology and immunopathology.

[46]  N. Leslie,et al.  Enzyme reconstitution/replacement therapy for lysosomal storage diseases , 2007, Current opinion in pediatrics.

[47]  P. Iadarola,et al.  Enzyme loaded biodegradable microspheres in vitro ex vivo evaluation. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[48]  M. Woodle,et al.  Controlling liposome blood clearance by surface-grafted polymers. , 1998, Advanced drug delivery reviews.

[49]  W. Sly,et al.  Human β-glucuronidase: In vivo clearance and in vitro uptake by a glycoprotein recognition system on reticuloendothelial cells , 1978, Cell.

[50]  Stephan Marsch,et al.  Toward intelligent nanosize bioreactors: a pH-switchable, channel-equipped, functional polymer nanocontainer. , 2006, Nano letters.

[51]  A. U. Daniels,et al.  Macrophage cytokine response to particles and lipopolysaccharide in vitro. , 2000, Journal of biomedical materials research.

[52]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[53]  Gerald D Fasman.  Handbook of Biochemistry , 1976 .

[54]  I. Hargreaves,et al.  ALLOGENEIC STEM CELL TRANSPLANTATION CORRECTS BIOCHEMICAL DERANGEMENTS IN MNGIE , 2007, Neurology.

[55]  C. Nathan,et al.  Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma. , 1985, Journal of immunology.

[56]  D. Gibbons,et al.  Cellular proliferation and cytokine responses of murine macrophage cell line J774A.1 to polymethylmethacrylate and cobalt-chrome alloy particles. , 1998, Journal of biomedical materials research.

[57]  Nily Dan,et al.  The effect of chain length on protein solubilization in polymer-based vesicles (polymersomes). , 2003, Biophysical journal.

[58]  I. Nishino,et al.  MNGIE: from nuclear DNA to mitochondrial DNA , 2001, Neuromuscular Disorders.

[59]  Dennis E. Discher,et al.  Polymer vesicles : Materials science: Soft surfaces , 2002 .

[60]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[61]  A. Graff,et al.  Virus-assisted loading of polymer nanocontainer , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[62]  S. Ichikawa,et al.  Enzymes inside lipid vesicles: preparation, reactivity and applications. , 2001, Biomolecular engineering.

[63]  Stephan Marsch,et al.  Cell-specific integration of artificial organelles based on functionalized polymer vesicles. , 2008, Nano letters.

[64]  P. Cullis,et al.  Drug Delivery Systems: Entering the Mainstream , 2004, Science.

[65]  Joseph Ryan,et al.  Enzymatic nanoreactors for environmentally benign biotransformations. 1. Formation and catalytic activity of supramolecular complexes of laccase and linear-dendritic block copolymers. , 2008, Biomacromolecules.

[66]  L. Wyns,et al.  Encapsulation of therapeutic nucleoside hydrolase in functionalised nanocapsules. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[67]  T. Allen,et al.  Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted liposomes. , 1996, Journal of pharmaceutical sciences.